HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhihong Zhang Selected Research

Cisplatin (Platino)

5/2019pH responsible and fluorescent Cy5.5-PEG-g-A-HA/CDDP complex nanoparticles: synthesis, characterization, and application for targeted drug delivery.
1/2019Imine Bond- and Coordinate Bond-Linked pH-Sensitive Cisplatin Complex Nanoparticles for Active Targeting to Tumor Cells.
8/2018Tumoral Acidic pH-Responsive cis-Diaminodichloroplatinum-Incorporated Cy5.5-PEG- g-A-HA Nanoparticles for Targeting Delivery of CDDP against Cervical Cancer.
1/2017Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhihong Zhang Research Topics

Disease

173Neoplasms (Cancer)
05/2024 - 07/2003
31Neoplasm Metastasis (Metastasis)
10/2023 - 01/2008
29Prostatic Neoplasms (Prostate Cancer)
10/2023 - 10/2006
21Inflammation (Inflammations)
05/2024 - 11/2005
21Stomach Neoplasms (Stomach Cancer)
07/2023 - 10/2010
20Carcinoma (Carcinomatosis)
05/2024 - 03/2002
17Carcinogenesis
04/2024 - 04/2005
17Breast Neoplasms (Breast Cancer)
08/2023 - 10/2005
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2010
11Peripheral Nervous System Diseases (PNS Diseases)
03/2023 - 01/2016
11Type 2 Diabetes Mellitus (MODY)
01/2022 - 09/2003
10Urinary Bladder Neoplasms (Bladder Cancer)
12/2024 - 10/2012
10Lung Neoplasms (Lung Cancer)
06/2023 - 01/2010
8Hypertension (High Blood Pressure)
01/2023 - 01/2013
8Melanoma (Melanoma, Malignant)
01/2021 - 06/2012
7Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 06/2010
7Hepatocellular Carcinoma (Hepatoma)
03/2024 - 01/2020
7Lymphatic Metastasis
05/2022 - 05/2012
7Obesity
12/2021 - 01/2013
7Myocardial Infarction
01/2021 - 05/2010
6Hypoxia (Hypoxemia)
04/2024 - 01/2014
6Asthma (Bronchial Asthma)
01/2024 - 01/2020
6Body Weight (Weight, Body)
01/2022 - 01/2018
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2014
5Cardiovascular Diseases (Cardiovascular Disease)
12/2024 - 01/2015
5Infections
06/2021 - 01/2018
5Peripheral Arterial Disease
03/2021 - 01/2019
4Colitis
05/2024 - 04/2020
4Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 05/2012
4Glioma (Gliomas)
04/2024 - 07/2003
4Insulin Resistance
02/2024 - 08/2012
4Infarction (Infarctions)
08/2020 - 04/2011
4Adenocarcinoma of Lung
11/2019 - 08/2017
4Hypersensitivity (Allergy)
01/2014 - 06/2009
3Calculi (Calculus)
03/2024 - 02/2014
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 01/2022
3Kidney Neoplasms (Kidney Cancer)
12/2023 - 01/2022
3Adenoma (Adenomas)
11/2023 - 07/2003

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2005
24Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2013
13NAD (NADH)IBA
03/2023 - 07/2004
13AntigensIBA
01/2023 - 07/2007
12Long Noncoding RNAIBA
07/2023 - 11/2014
12ElementsIBA
12/2015 - 11/2009
11Glucose (Dextrose)FDA LinkGeneric
11/2021 - 07/2003
10Messenger RNA (mRNA)IBA
02/2024 - 03/2015
10CytokinesIBA
01/2024 - 01/2018
10Small Interfering RNA (siRNA)IBA
09/2020 - 09/2009
9ErbB Receptors (EGF Receptor)IBA
12/2023 - 01/2016
9Peptides (Polypeptides)IBA
08/2023 - 02/2010
8MicroRNAs (MicroRNA)IBA
08/2023 - 04/2005
7Therapeutic UsesIBA
04/2024 - 11/2005
7Caspase 3 (Caspase-3)IBA
02/2023 - 10/2005
7Lipid NanoparticlesIBA
01/2023 - 02/2010
7Indicators and Reagents (Reagents)IBA
01/2023 - 09/2008
7Metal-Organic FrameworksIBA
06/2021 - 01/2019
7Phosphotransferases (Kinase)IBA
12/2019 - 05/2006
6Circulating Tumor DNAIBA
05/2024 - 06/2019
6Particulate MatterIBA
10/2023 - 08/2015
6Triglycerides (Triacylglycerol)IBA
08/2023 - 06/2011
6N- succinimidyl- 3- (4- hydroxyphenyl)propionate (HPPS)IBA
08/2023 - 01/2010
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2013
6AcidsIBA
05/2019 - 10/2004
6Prostate-Specific Antigen (Semenogelase)IBA
01/2019 - 04/2011
6Epidermal Growth Factor (EGF)IBA
01/2019 - 01/2010
5Tyrosine Kinase InhibitorsIBA
03/2024 - 08/2017
5CholesterolIBA
08/2023 - 12/2012
5Melitten (Melittin)IBA
08/2023 - 07/2013
5Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2018
5LipidsIBA
01/2023 - 02/2010
5Untranslated RNA (Noncoding RNA)IBA
09/2022 - 01/2018
5CreatinineIBA
12/2021 - 11/2018
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 11/2006
5LigandsIBA
06/2021 - 01/2010
4Dextran SulfateIBA
05/2024 - 04/2020
4Blood Glucose (Blood Sugar)IBA
02/2024 - 11/2018
4Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 06/2011
4Lysine (L-Lysine)FDA Link
12/2023 - 09/2008
4AntimonyIBA
10/2023 - 05/2018
4oxidized low density lipoproteinIBA
08/2023 - 06/2004
4HDL CholesterolIBA
08/2023 - 01/2020
4LDL CholesterolIBA
08/2023 - 10/2021
4HDL LipoproteinsIBA
08/2023 - 11/2009
4Matrix Metalloproteinases (MMPs)IBA
08/2023 - 03/2007
4graphene oxideIBA
08/2023 - 01/2017
4CateninsIBA
01/2022 - 03/2016
4CarbonIBA
06/2021 - 06/2019
4Transcription Factors (Transcription Factor)IBA
09/2019 - 01/2015
4Cisplatin (Platino)FDA LinkGeneric
05/2019 - 01/2017
4IronIBA
03/2019 - 01/2015
4lysophosphatidic acidIBA
01/2016 - 10/2009
4Succinic Acid (Succinate)IBA
09/2014 - 10/2010
31-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2023 - 07/2003

Therapy/Procedure

55Therapeutics
05/2024 - 10/2005
16Immunotherapy
01/2023 - 01/2016
13Drug Therapy (Chemotherapy)
04/2024 - 08/2011
9Radiotherapy
04/2024 - 06/2010
5Operative Time
12/2024 - 05/2012
4Photochemotherapy (Photodynamic Therapy)
01/2023 - 07/2003
3Peritoneal Dialysis
12/2024 - 03/2021